Filter
323
Filtered Results: 323
Text search:
bacteriología
de
tuberculosis
Featured
Recommendations
34
New Publications
50
Language
Document type
No document type
190
Guidelines
51
Studies & Reports
35
Manuals
26
Strategic & Response Plan
16
Training Material
3
Situation Updates
1
Fact sheets
1
Countries / Regions
Western and Central Europe
38
Eastern Europe
25
Colombia
11
Senegal
10
El Salvador
10
Latin America and the Carribbean
10
Argentina
9
Peru
9
Paraguay
9
India
8
Rwanda
8
Bolivia
6
Ecuador
5
Kenya
4
Tanzania
4
Brazil
4
Africa
4
Sierra Leone
3
Chile
3
Burkina Faso
2
Nigeria
2
Ethiopia
2
Nepal
2
Germany
2
Cambodia
2
Bangladesh
2
Venezuela
2
Global
2
Uruguay
2
Congo, Democratic Republic of
1
Mali
1
Cameroon
1
Ghana
1
Uganda
1
Philippines
1
Zambia
1
China
1
Indonesia
1
South Africa
1
Dominican Republic
1
Namibia
1
Lesotho
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Romania
1
Georgia
1
Vietnam
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
45
Pharmacy & Technologies
12
Public Health
8
Key Resources
7
Women & Child Health
5
Capacity Building
1
Toolboxes
TB
206
AMR
22
NTDs
14
Polio
8
HIV
6
Ebola
4
Rapid Response
4
Pharmacy
4
Refugee
3
COVID-19
3
Caregiver
3
Conflict
2
Disability
1
Natural Hazards
1
Zika
1
Mental Health
1
Specific Hazards
1
Global Health Education
1
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculos... and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagnostics are highly accurate, cost-effective, reduce the time to treatment initiation, and impact patient-important outcomes.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context...
3rd edition
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an...
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Policy statement.
CẨM NANG AN TOÀN SINH HỌC PHÒNG XÉT NGHIỆM LAO.
NHÀ XUẤT BẢN Y HỌC HÀ NỘI - 2015.
International Journal of Infectious Diseases 32 (2015) 111–117
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment ...
